Interesting that they have not said what it is. Was able to partially listen to the call this morning. Went to print the slides and had an issue. In addition, there were about 12/13 slides that I could not see. Three interesting follow-ups so far:
1. AT13387 is also starting a PH 2 solid tumor trial in Q4. This was not on any other previous slides.
2. As we talked about AT7519 Phase 2 results is off the Q4 events schedule. This is either a bust or hopefully, Novartis has partnered with the drug. Maybe Novartis will present the results?
3. As you said Free, SGI-110 will start another "solid tumor" trial in Q4. We are not sure which one. Appears they will announce in Q4 what it is.
Did not include that SGI-110 will be starting Phase 2 Ovarian Cancer trial in Q4.
Lots of changes even from the Sept 10th presentation.